SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Rasagiline Teva 1 mg tablets 2. QUALITATIVE AND QUANTITATIVE
![Teva : Favorable Court Ruling in AZILECT Patent Infringement Litigation Against Mylan - Jewish Business News Teva : Favorable Court Ruling in AZILECT Patent Infringement Litigation Against Mylan - Jewish Business News](https://media.jewishbusinessnews.com/2013/09/20030853/imgres13.jpg)
Teva : Favorable Court Ruling in AZILECT Patent Infringement Litigation Against Mylan - Jewish Business News
![Rasagiline Tablet Market Growth 2023-2029 Research Report by Key - NEWSnet - News... as it used to be Rasagiline Tablet Market Growth 2023-2029 Research Report by Key - NEWSnet - News... as it used to be](https://absolutereports.images.worldnow.com/images/24478366_G.png?auto=webp&disable=upscale&height=560&fit=bounds&lastEditedDate=1682733841000)
Rasagiline Tablet Market Growth 2023-2029 Research Report by Key - NEWSnet - News... as it used to be
![These highlights do not include all the information needed to use AZILECT® safely and effectively. See full prescribing information for AZILECT. AZILECT (rasagiline) Tablets for Oral Use Initial U.S. Approval: 2006 These highlights do not include all the information needed to use AZILECT® safely and effectively. See full prescribing information for AZILECT. AZILECT (rasagiline) Tablets for Oral Use Initial U.S. Approval: 2006](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-4.jpg&id=643101)
These highlights do not include all the information needed to use AZILECT® safely and effectively. See full prescribing information for AZILECT. AZILECT (rasagiline) Tablets for Oral Use Initial U.S. Approval: 2006
![TEVA recupera la comercialización de Azilect, fármaco para el tratamiento del Parkinson - Geriatricarea TEVA recupera la comercialización de Azilect, fármaco para el tratamiento del Parkinson - Geriatricarea](http://geriatricarea.com/wp-content/uploads/2016/01/Geriatricarea-Azilect-rasagilina-TEVA.jpg)